Citations

Showing 10 of 108083 citations.

Quantifying infective endocarditis risk in patients with predisposing cardiac conditions
Thornhill, Martin H. , Jones, Simon , Prendergast, Bernard , Chambers, John B. , Lockhart, Peter B. , Thornhill, M H , Baddour, Larry M. , Dayer, Mark

Mayo Clinic

European Heart Journal | October 24, 2017 | Volume: 39 | Issue: 7 | Pages: 586-595

10.1093/eurheartj/ehx655 | PMID 29161405 Get It

Abstract Aims There are scant comparative data quantifying the risk of infective endocarditis (IE) and associated mortality in individuals with predisposing cardiac conditions. Methods and results English hospital admissions for conditions associated with increased IE risk were followed for 5 years to quantify subsequent IE admissions. The 5-year risk of IE or dying during an IE admission was calculated for each condition and compared with the entire English population as a control. Infective endocarditis incidence in the English population was 36.2/million/year. In comparison, patients with a previous history of IE had the highest risk of recurrence or dying during an IE admission [odds ratio (OR) 266 and 215, respectively]. These risks were also high in patients with prosthetic valves (OR 70 and 62) and previous valve repair (OR 77 and 60). Patients with congenital valve anomalies (currently considered ‘moderate risk’) had similar levels of risk (OR 66 and 57) and risks in other ‘moderate-risk’ conditions were not much lower. Congenital heart conditions (CHCs) repaired with prosthetic material (currently considered ‘high risk’ for 6 months following surgery) had lower risk than all ‘moderate-risk’ conditions—even in the first 6 months. Infective endocarditis risk was also significant in patients with cardiovascular implantable electronic devices. Conclusion These data confirm the high IE risk of patients with a history of previous IE, valve replacement, or repair. However, IE risk in some ‘moderate-risk’ patients was similar to that of several ‘high-risk’ conditions and higher than repaired CHC. Guidelines for the risk stratification of conditions predisposing to IE may require re-evaluation.
Reply to “Modern Hematology Analyzers Are Very Useful for Diagnosis of Malaria and, Crucially, May Help Avoid Misdiagnosis”
Mathison, Blaine A. , Pritt, Bobbi S. , Pritt, Bobbi S , Mathison, Blaine A

Mayo Clinic

Journal of Clinical Microbiology | October 24, 2017 | Volume: 55 | Issue: 11 | Pages: 3305-3305

10.1128/jcm.01206-17 | PMID 29066566 Get It

The Southampton Consensus Guidelines for Laparoscopic Liver Surgery
Hilal, Mohammad Abu , Aldrighetti, Luca , Dagher, Ibrahim, Troisi, Roberto , Alikhanov, Ruslan , Aroori, Somaiah , Belli, Giulio, Besselink, Marc G. , Briceño, Javier , Gayet, Brice, D’Hondt, Mathieu , Lesurtel, Mickaël , Menon, Krishna , Lodge, Peter, Rotellar, Fernando , Santoyo, Julio Santoyo , Scatton, Olivier , Sutcliffe, Robert P. , Dam, Ronald M. van , White, Steve, Halls, Mark , Cipriani, Federica , Poel, M. van der, Ciria, Rubén , Barkhatov, Leonid , Gomez-Luque, Yrene, Ocana-Garcia, Sira, Cook, Andrew , Buell, Joseph F. , Clavien, Pierre‐Alain , Dervenis, Christos, Fusai, Giuseppe , Lang, Hauke , Primrose, John , Taylor, Mark , Gulik, Thomas van , Wakabayashi, Go , Asbun, Horacio J. , Cherqui, Daniel , Asbun, Horacio, Ciria, Ruben , Aldrighetti, Luca , Edwin, Bjørn , Besselink, Marc G , Soubrane, Olivier , Poel, Marcel J. van der , Geller, David A. , Rotellar, Fernando , Lesurtel, Mickaël , Cipriani, Federica

Mayo Clinic

Annals of Surgery | October 24, 2017 | Volume: 268 | Issue: 1 | Pages: 11-18

10.1097/sla.0000000000002524 | PMID 29064908 Get It

Objective: The European Guidelines Meeting on Laparoscopic Liver Surgery was held in Southampton on February 10 and 11, 2017 with the aim of presenting and validating clinical practice guidelines for laparoscopic liver surgery. Background: The exponential growth of laparoscopic liver surgery in recent years mandates the development of clinical practice guidelines to direct the speciality's continued safe progression and dissemination. Methods: A unique approach to the development of clinical guidelines was adopted. Three well-validated methods were integrated: the Scottish Intercollegiate Guidelines Network methodology for the assessment of evidence and development of guideline statements; the Delphi method of establishing expert consensus, and the AGREE II-GRS Instrument for the assessment of the methodological quality and external validation of the final statements. Results: Along with the committee chairman, 22 European experts; 7 junior experts and an independent validation committee of 11 international surgeons produced 67 guideline statements for the safe progression and dissemination of laparoscopic liver surgery. Each of the statements reached at least a 95% consensus among the experts and were endorsed by the independent validation committee. Conclusion: The European Guidelines Meeting for Laparoscopic Liver Surgery has produced a set of clinical practice guidelines that have been independently validated for the safe development and progression of laparoscopic liver surgery. The Southampton Guidelines have amalgamated the available evidence and a wealth of experts’ knowledge taking in consideration the relevant stakeholders’ opinions and complying with the international methodology standards.
Combination therapy incorporating Bcl‐2 inhibition with Venetoclax for the treatment of refractory primary plasma cell leukemia with t (11;14)
Gonsalves, Wilson I. , Kumar, Shaji , Buadi, Francis K. , Gonsalves, Wilson

Mayo Clinic

European Journal of Haematology | October 24, 2017 | Volume: 100 | Issue: 2 | Pages: 215-217

10.1111/ejh.12986 | PMID 29064593 Get It

AbstractPrimary plasma cell leukemia (pPCL) is the most aggressive form of the plasma cell (PC) malignancy, multiple myeloma (MM). It has been commonly associated with the presence of a chromosome translocation involving the immunoglobulin heavy chain (IgH) locus on 14q32, that is t (11;14). Results from early phase clinical trials utilizing the selective Bcl‐2 inhibitor, venetoclax, as a single agent in patients with relapsed MM have had remarkable efficacy among patients with t (11;14) abnormality. The present case demonstrates the ability of a combination regimen incorporating Bcl‐2 inhibition with daratumumab, bortezomib, venetoclax, and dexamethasone to induce a rapid and very deep hematologic response in a pPCL patient with t (11;14), even in a setting of very refractory disease. This case highlights the need to further study Bcl‐2 inhibition‐based therapy as an option for therapy in patients with pPCL with t (11;14).
A Mayo Clinic 13‐year investigation of the syndrome of rapid onset ESRD among renal transplant recipients: An analysis of the implications of renal allograft biopsy results
Agbasi, Nneoma, Onuigbo, Macaulay Amechi, Onuigbo, Macaulay

Mayo Clinic

Hemodialysis International | October 24, 2017 | Volume: 21 | Issue: S2 | Pages: No page available

10.1111/hdi.12597 | PMID 29064181 Get It

AbstractIntroduction: We first described the syndrome of rapid onset end stage renal disease (SORO‐ESRD), acute yet irreversible renal failure, in 2010.Objective: The impact of SORO‐ESRD renal allograft survival remains speculative and we plan to study this question.Methods: A retrospective analysis of individual adult patient‐level serum creatinine trajectories of ESRD patients on maintenance hemodialysis for >90 days at Mayo Clinic, Rochester, 2001–2013.Results: Of 1461 ESRD patients, 149 (10%) patients including 13 renal transplant recipients (RTRs) satisfied the diagnosis of SORO‐ESRD ‐ 4 males, 9 females, 12 Caucasians/one other, age 45 (18–83) years. Serum creatinine was 1.4 (0.8–1.7) mg/dL in the last year before hemodialysis initiation. Initial hemodialysis access was a dialysis catheter in all 13 patients. AKI precipitating SORO‐ESRD followed acute rejection (4), postoperative (2), tubulo‐interstitial nephritis (2), unknown (2), infection/sepsis (1), contrast nephropathy (1), BKV nephropathy (1), and cardio‐renal syndrome (1). Renal allograft survival was 1469 (277–4939) days (4 years). Renal allograft biopsies were available in 9/14 (69%) RTRs ‐ Four showed acute rejection, two of which followed interruption of immunosuppression, three revealed acute tubular necrosis and four others also showed chronic transplant glomerulopathy. Time on hemodialysis was 856 (129–1630) days (2.4 years). 5/13 RTRs with SORO‐ESRD (38%) died ‐ 3 (60%) following cardiac arrest, 2 (40%) after stopping hemodialysis. 4/13 (31%) were re‐transplanted in the period of this study.Conclusion: SORO‐ESRD contributed significantly to late renal allograft loss and return to hemodialysis with 100% initial dialysis catheter rate. Potentially preventable causes of AKI leading to SORO‐ESRD were identified. The application of experience gained from such studies would help reduce late renal allograft loss and the need for re‐transplantation. This would further help reduce the yawning gap between need and availability of donor kidney organs both here in the United States and around the world. Larger studies are warranted.
National Multispecialty Survey Results: Comparing Morbidity and Mortality Conference Practices within and outside Otolaryngology
Balakrishnan, Karthik , Arjmand, Ellis M., Snyderman, Carl, Nussenbaum, Brian A. , Balakrishnan, Karthik

Mayo Clinic

Otolaryngology–Head and Neck Surgery | October 24, 2017 | Volume: 158 | Issue: 2 | Pages: 273-279

10.1177/0194599817737993 | PMID 29064313 Get It

ObjectiveThe objective is to describe variations in the otolaryngology morbidity and mortality (M&M) conference and to compare with other specialties.DesignCross‐sectional survey.SettingThe setting included otolaryngology departments across the United States and nonotolaryngology medical and surgical departments at 4 academic medical centers.Subjects and MethodsParticipants were members of a national otolaryngology quality/safety network and nonotolaryngology quality leaders at 4 large academic hospitals. Surveys were administered January 2017. Respondents described M&M conference practices, goals, and educational role.ResultsTwenty‐eight of 39 individuals representing 28 institutions completed the otolaryngology survey (72% response rate). Of 197 individuals, 60 (30% response rate) representing 11 surgical and 20 nonsurgical specialties completed the comparison survey. Twenty‐seven of 28 otolaryngologists (46 of 60 nonotolaryngologists) worked in academic settings. All otolaryngology programs conducted an M&M conference: 54% discussed all adverse events and errors; 32% used standard case selection processes; 70% used structured discussion, usually root cause analysis (64%); and 32% classified harm level. In comparison with other specialties, otolaryngology programs were more likely to discuss all adverse events and errors (P =. 01). Most conferences led to quality projects and intrainstitutional communication: 22% communicated to patients and families; 73% of respondents thought that M&M conferences should be standardized or use “best practices.” In both surveys, improving patient care was rated the conference’s most important function, followed by trainee education and culture change. Patient care and practice‐based learning were rated the most relevant Accreditation Council for Graduate Medical Education Core Competencies in both surveys.ConclusionsAcademic otolaryngology M&M practices generally align with other specialties, but specifics vary widely, making collaborative quality improvement challenging. Educational and administrative priorities cross specialties. Most respondents thought that standardization and best practices are worthwhile. Nonacademic practice data are needed.
Ureteroscopic Laser Lithotripsy: A Review of Dusting vs Fragmentation with Extraction
Matlaga, Brian R., Eisner, Brian H. , Humphreys, Mitchell R. , Knudsen, Bodo E. , Krambeck, Amy E. , Lange, Dirk , Lipkin, Michael E. , Miller, Nicole L. , Monga, Manoj, Pais, Vernon M., Sur, Roger L. , Shah, Ojas , Humphreys, Mitchell, Krambeck, Amy, Chew, Ben H. , Miller, Nicole L

Mayo Clinic

Journal of Endourology | October 24, 2017 | Volume: 32 | Issue: 1 | Pages: 1-6

10.1089/end.2017.0641 | PMID 29061070 Get It

B-cell–targeted therapies in relapsing forms of MS
Dubey, Divyanshu , Forsthuber, Thomas G. , Pittock, Sean J. , Forsthuber, Thomas, Stüve, Olaf, Pittock, S J , Dubey, Divyanshu , Flanagan, Eoin P. , Stüve, Olaf

Mayo Clinic

Neurology Neuroimmunology & Neuroinflammation | October 24, 2017 | Volume: 4 | Issue: 6 | Pages: No page available

10.1212/nxi.0000000000000405 | PMID 29082296 Get It

Alveolar air and oxidative metabolic demand during exercise in healthy adults: the role of single-nucleotide polymorphisms of the β 2 AR gene
Iterson, Erik H. Van , Snyder, Eric M., Johnson, Bruce D., Van Iterson, Erik H

Mayo Clinic

Physiological Reports | October 23, 2017 | Volume: 5 | Issue: 20 | Pages: e13476

10.14814/phy2.13476 | PMID 29061864 Get It

Head flutter
Lemos, João , Duque, Cristina , Araújo, Rui , Castelhano, João , Eggenberger, Eric , Nunes, Carla , Lemos, João

Mayo Clinic

Neurology | October 23, 2017 | Volume: 89 | Issue: 17 | Pages: 1841-1841

10.1212/wnl.0000000000004583 | PMID 29061674 Get It